The themes Journey Medical is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Built from Journey Medical Corp’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
DERM · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic
$4.46+0.8%Nov 11 close
Reported results on November 12, 2026; they are not in these figures yet.
The latest quarter (ended September 30, 2026) is from Journey Medical’s earnings press release of November 12, 2026. It will be replaced by the official quarterly report (10-Q) once Journey Medical files it.
Grade C-
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 18 quarters of Journey Medical Corp’s grade history. The other 16 go back to August 2022.